abstract |
The invention relates to the field of biochemistry, in particular to the use of antibodies specific for CD19 and fludarabine for obtaining a synergistic combination for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and / or acute lymphoblastic leukemia. The invention effectively treats non-Hodgkin's lymphoma, chronic lymphocytic leukemia and / or acute lymphoblastic leukemia. 6 hp f-ly, 7 ill., 11 tablets., 3 ex. |